Capricor Therapeutics Inc. (CAPR)
Market Open
11 Sep, 14:01
$
8. 48
+0.18
+2.1687%
$
521.05M Market Cap
- P/E Ratio
- Div Yield
315,366 Volume
- Eps
$ 8.3
Previous Close 
Want to track CAPR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Capricor Therapeutics Inc. (CAPR) Statistics
Valuation metrics
Market Cap 521.05M
Enterprise value 610.71M
Trailing P/E (ttm) -3.84
Forward P/E -37.7
PEG ratio 0.1
Price/Sales (ttm) 74.65
Price/Book (mrq) 2.21
Enterprise Value/Revenue 74.8
Enterprise Value/EBITDA 0.52
Overview
Shares outstanding 57.37M
Float 48.96M
Shares short 10.52M
% Held by insiders 0.09%
% Held by institutions 0.59%
Average volume (10 days) 2.54M
Average volume (90 days) 7.76M
Price summary
52-Week low 2.96
52-Week high 40.37
Beta 0.48
50-Day moving average 7.91
200-Day moving average 28.17
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 5 Jun 2019
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -1.91%
Operational effectiveness
Return on assets -0.35%
Return on equity -0.57%
Income Statement
Revenue (ttm) 22.27M
Revenue per share (ttm) 0.63
Quarterly revenue growth (yoy) -
Gross profit (ttm) -92.92M
EBITDA -117.91M
Net income to common (ttm) -114.59M
Diluted EPS (ttm) -2.23
Quarterly earnings growth (yoy) -1%
Balance Sheet
Total cash (mrq) 278.61M
Total cash per share (mrq) 4.11
Total debt (mrq) 14.78M
Total Debt/Equity (mrq) 0.37
Current ratio (mrq) 7.35%
Book value per share (mrq) 4.25
Cash Flow
Cash flow statement -92.63M
Levered free cash flow (LFCF) -70.47M
